Oncology Commercial Assessment

The head of commercial development at a global biopharma giant was assessing the outlook for several oncology indications in key Asian markets. The team had already secured secondary research sources, and it had contracted with external agencies to conduct primary research. However, there was no one who could drive the analysis and create a comprehensive commercial assessment.

Business Talent Group delivered a senior life science leader who’d previously worked in BCG’s healthcare practice and headed Sanofi’s oncology strategy division. Experienced, pragmatic, and not afraid to dive into a complex landscape of treatment options and unmet medical needs, he helped the client synthesize data and size market opportunities. The client then used this analysis to finalize broader market strategies.

About the Author

Leah Hoffmann

Leah Hoffmann is a former journalist who has worked for Forbes.com and The Economist. She is passionate about clear thinking, sharp writing, and strong points of view.

More Content by Leah Hoffmann
Previous Article
Preparing a Biopharma Congress Plan
Preparing a Biopharma Congress Plan

A global biopharma company was preparing to launch two promising bone health therapies. To maximize impact,...

Next Article
Assessing New Recycling Models
Assessing New Recycling Models

The baby care division at a global consumer goods company was assessing the feasibility of a new approach t...


Talk with BTG to learn more about our on-demand talent.

First Name
Last Name
I would like to receive the latest expert insights and news from Business Talent Group.
By registering, you agree to the processing of your personal data by Business Talent Group as described in the Privacy Statement.
View our Privacy Policy and Cookie Policy
Thank you! We will be in touch shortly.
Error - something went wrong!